Skip to main content
Inpatient Procedure Code

3E0B3GC ICD-10-PCS Code: Introduction of Other Therapeutic Substance into Ear, Percutaneous Approach

Introduction of Oth Therap Subst into Ear, Perc Approach

Axis Breakdown

Every ICD-10-PCS code is exactly seven characters, one per axis. Each character's meaning is defined by its position in the code.

PositionValueMeaning
1
Section3

Administration

2
Body SystemE

Physiological Systems and Anatomical Regions

3
Root Operation0

Introduction

Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products

4
Body System / RegionB

Ear

5
Approach3

Percutaneous

6
SubstanceG

Other Therapeutic Substance

7
QualifierC

Other Substance

Related Codes

Same operation — other Body System / Region

Same table and root operation, differing only in the body system / region character.

3E073GC — Introduction of Other Therapeutic Substance into Coronary Artery, Percutaneous Approach, 3E083GC — Introduction of Other Therapeutic Substance into Heart, Percutaneous Approach, 3E093GC — Introduction of Other Therapeutic Substance into Nose, Percutaneous Approach, 3E0A3GC — Introduction of Other Therapeutic Substance into Bone Marrow, Percutaneous Approach, 3E0C3GC — Introduction of Other Therapeutic Substance into Eye, Percutaneous Approach, 3E0D3GC — Introduction of Other Therapeutic Substance into Mouth and Pharynx, Percutaneous Approach, 3E0E3GC — Introduction of Other Therapeutic Substance into Products of Conception, Percutaneous Approach, 3E0F3GC — Introduction of Other Therapeutic Substance into Respiratory Tract, Percutaneous Approach, +23 more

Same operation — other Approach

Same table and root operation, differing only in the approach character.

3E0B7GC — Introduction of Other Therapeutic Substance into Ear, Via Natural or Artificial Opening, 3E0BXGC — Introduction of Other Therapeutic Substance into Ear, External Approach

Same procedure category (CCSR), other tables

AHRQ's Clinical Classifications Software Refined groups these ICD-10-PCS procedures with this one under Administration of therapeutic substances, NEC (Administration of Therapeutic Substances); listed here are the members in other PCS tables. Source: Clinical Classifications Software Refined (CCSR), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, November 2025.

XW00X27 — Introduction of Anacaulase-bcdb into Skin, External Approach, New Technology Group 7, XW0136A — Introduction of Dasiglucagon into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 10, XW01397 — Introduction of Satralizumab-mwge into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 7, XW013TB — Introduction of Rozanolixizumab-noli Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 11, XW013W5 — Introduction of Caplacizumab into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 5, XW01X27 — Introduction of Anacaulase-bcdb into Subcutaneous Tissue, External Approach, New Technology Group 7, XW0333A — Introduction of Bentracimab, Ticagrelor Reversal Agent into Peripheral Vein, Percutaneous Approach, New Technology Group 10, XW03372 — Introduction of Inactivated Coagulation Factor Xa into Peripheral Vein, Percutaneous Approach, New Technology Group 2, XW03377 — Introduction of Trilaciclib into Peripheral Vein, Percutaneous Approach, New Technology Group 7, XW033F3 — Introduction of Other New Technology Therapeutic Substance into Peripheral Vein, Percutaneous Approach, New Technology Group 3, XW033FA — Introduction of Non-Chimeric Antigen Receptor T-cell Immune Effector Cell Therapy into Peripheral Vein, Percutaneous Approach, New Technology Group 10, XW033FB — Introduction of Valoctocogene Roxaparvovec-rvox into Peripheral Vein, Percutaneous Approach, New Technology Group 11, XW033MA — Introduction of Emapalumab-lzsg Anti-IFNy Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 10, XW033Q9 — Introduction of Posoleucel into Peripheral Vein, Percutaneous Approach, New Technology Group 9, XW033QB — Introduction of Iloprost into Peripheral Vein, Percutaneous Approach, New Technology Group 11, XW033R9 — Introduction of Rezafungin into Peripheral Vein, Percutaneous Approach, New Technology Group 9, XW033W5 — Introduction of Caplacizumab into Peripheral Vein, Percutaneous Approach, New Technology Group 5, XW0433A — Introduction of Bentracimab, Ticagrelor Reversal Agent into Central Vein, Percutaneous Approach, New Technology Group 10, XW04372 — Introduction of Inactivated Coagulation Factor Xa into Central Vein, Percutaneous Approach, New Technology Group 2, XW04377 — Introduction of Trilaciclib into Central Vein, Percutaneous Approach, New Technology Group 7, +38 more

Contextual Map

Every relationship of 3E0B3GC in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.

PCS table

Clinical classification (CCSR)

Nearest codes

Change history

No changes recorded for this code. This ledger tracks additions, deletions and description changes from FY2026 (April) onward. Note changes are not tracked.

Read from: CMS ICD-10-PCS code tables, index and definitions — FY2026 (April); CMS MS-DRG Definitions Manual (incl. Appendix B diagnosis index, Appendix C CC/MCC list, Appendix E procedure index) and IPPS Final Rule tables — v43; AHRQ HCUP Clinical Classifications Software Refined for ICD-10-PCS Procedures (hcup-us.ahrq.gov/toolssoftware/ccsr/PRCCSR_v2026-1.zip) — v2026.1. All data sources · How to read the labels